Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)

Study Overview
=================
Brief Summary
-----------------
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.

Detailed Description
-----------------
The main objective is to improve the knowledge of carcinosis mechanisms to develop a specific treatment. That's why this blood collection and tissue collection is very important for the future, these collection will be permitted to the scientists to develop a research specially for carcinosis.

Official Title
-----------------
Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis

Conditions
-----------------
Cancer, Peritoneal Carcinosis

Intervention / Treatment
-----------------
* Biological: biological collection
* Other: Tissues collections


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient over the age of 18; Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease Patient agree will all study procedure : biological samples & tissues samples Patient giving informed consent Exclusion Criteria: Patient not affiliated to Social Protection system Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons The level of French is insufficient to consent to the study and to response to the questionnaires Patient under guardianship Pregnancy ou breast-feeding women Patient treated in case of an emergency

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Tumors and blood collection<br>For all the patients include in the study : Blood samples will be collected at different times : before any treatment, at every surgery, one month after any surgery, at progression. Tumours and not tumours tissues will be collected at different times : Before any surgery, one month after any surgery In parallel to this biological collection, standardized clinical data will be entered into a database treatment, at every surgery | Biological: biological collection<br>* Blood samples collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression<br>Other: Tissues collections<br>* Tumours and not tumours tissues will be collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Proportion of patients who gave their consent to participate in the study | The proportion of patients who consent to participate in the study among the screened patients | Until the study completion: 4 years |